Page last updated: 2024-08-24

sertraline and Cardiac Diseases

sertraline has been researched along with Cardiac Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blow, FC; Bohnert, AS; Ganoczy, D; Kales, HC; Nallamothu, BK; Pfeiffer, PN; Zivin, K	1
Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hinderliter, A; Hoffman, BM; Johnson, JJ; O'Connell, C; Patidar, SM; Rogers, SD; Sherwood, A; Watkins, L; Waugh, R	1

Trials

1 trial(s) available for sertraline and Cardiac Diseases

Article	Year
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues. Clinical trials (London, England), 2007, Volume: 4, Issue:5 Topics: Adult; Antidepressive Agents; Biomarkers; Depression; Endpoint Determination; Exercise; Female; Heart Diseases; Humans; Male; Placebos; Randomized Controlled Trials as Topic; Sertraline; United States	2007

Article

Year

Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.

Clinical trials (London, England), 2007, Volume: 4, Issue:5

Topics: Adult; Antidepressive Agents; Biomarkers; Depression; Endpoint Determination; Exercise; Female; Heart Diseases; Humans; Male; Placebos; Randomized Controlled Trials as Topic; Sertraline; United States

2007

Other Studies

1 other study(ies) available for sertraline and Cardiac Diseases

Article	Year
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. The American journal of psychiatry, 2013, Volume: 170, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration	2013

Article

Year

Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.

The American journal of psychiatry, 2013, Volume: 170, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration

2013